Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02155257 · ClinicalTrials.gov registry record · Phase 4
Pain Expectations in Subjects With Osteoarthritis
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT02155257 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 30 participants.
The verdict
NCT02155257, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this research study is to test whether or not researchers can alter or change expectations on pain. The researchers will test whether there is an effect on the size of the pupil and responses to thermal heat temperatures in subjects with osteoarthritis of the knee or hip or healthy subjects for comparison. One of 3 possible treatment groups will be administered to qualifying subjects: (1) gabapentin, a medication that is commonly used to treat nerve pain, (2) modafinil, a medication that is commonly used to treat people with narcolepsy (a disorder that causes people to fall asleep) and (3) a placebo, which is an inactive substance, like a sugar pill, that is not thought to have any effect on your disease or condition
Interventions
- DRUG Placebo
- DRUG Modafinil
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02155257
The ClinicalTrials.gov registry entry for NCT02155257 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02155257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02155257 about?
NCT02155257 is a clinical study titled "Pain Expectations in Subjects With Osteoarthritis". The purpose of this research study is to test whether or not researchers can alter or change expectations on pain. The researchers will test whether there is an effect on the size of the pupil and responses to thermal heat temperatures in subjects with osteoarthritis of the knee or hip or healthy su...
What is the current status of trial NCT02155257?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2014-07. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02155257?
The interventions under investigation include: Placebo (DRUG), Modafinil (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT02155257?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.